Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line
Diabetes · 01.02.2025 · 74 (2) · 188-198
DOI: 10.2337/db24-0756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 19.11.2024. Verfasst von Samantha Mar und 7 weiteren Autor:innen. Beteiligte Einrichtung: BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Glucagon, Human Embryonic Stem Cells, Insulin, Glucagon-Secreting Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Michael Smith Foundation for Health Research, Canadian Islet Research and Training Network Award, Breakthrough T1D.
Abstract (Originalsprache)
Human embryonic stem cell (hESC)-derived pancreatic α- and β-cells can be used to develop cell replacement therapies to treat diabetes. However, recent published differentiation protocols yield varying amounts of α- and β-cells amid heterogeneous cell populations. To visualize and isolate hESC-derived α- and β-cells, we generated a GLUCAGON-2A-mScarlet and INSULIN-2A-EGFP dual fluorescent reporter (INSEGFPGCGmScarlet) hESC line using CRISPR/Cas9. We established robust expression of EGFP and mScarlet fluorescent proteins in insulin- and glucagon-expressing cells, respectively, without compromising the differentiation or function of these cells. We also showed that the insulin- and glucagon-expressing bihormonal population at the maturing endocrine cell stage (stage 6) of our pancreatic islet differentiation lose insulin expression over time, while maintaining an α-like expression profile, suggesting these bihormonal cells are cell-autonomously fated to become α-like cells. We also demonstrated this cell line can be used to monitor hESC-derived insulin- and glucagon-expressing cells, and hESC-derived islet morphology in vivo, by transplanting them into the anterior chamber of the eye in mice. Together, the INSEGFPGCGmScarlet hESC line provides an efficient strategy for tracking populations of hESC-derived β- and α-like cells. Article Highlights Differentiation protocols used to generate stem cell–derived islet cells yield heterogenous cell populations. We generated a human embryonic stem cell line that reports insulin- and glucagon-expressing cells in vitro and in vivo without altering their differentiation or function. We showed some insulin- and glucagon-expressing bihormonal cells are cell-autonomously fated to become α-like cells. This reporter cell line can be used to further study and improve stem cell–derived islet differentiation and transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- School of Biomedical Engineering, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Francis C Lynn
Förderung
- Michael Smith Foundation for Health Research
- Canadian Islet Research and Training Network Award
- Breakthrough T1D
- CIHR
- BCCHR IGAP
- UBC CELL Graduate Program 1YF
- JDRF
- Canadian Institutes of Health Research
Zitieren
APA
Mar, S., Filatov, E., Sasaki, S., Mojibian, M., Zhang, D., Yang, A., Nian, C., & Lynn, F. C. (2025). Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line. Diabetes, 74(2), 188-198. https://doi.org/10.2337/db24-0756
Vancouver
Mar S, Filatov E, Sasaki S, Mojibian M, Zhang D, Yang A, et al. Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line. Diabetes. 2025;74(2):188-198. doi:10.2337/db24-0756
BibTeX
@article{Mar2025,
author = {Mar, Samantha and Filatov, Ekaterina and Sasaki, Shugo and Mojibian, Majid and Zhang, Dahai and Yang, Angela and Nian, Cuilan and Lynn, Francis C},
title = {Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {2},
pages = {188--198},
doi = {10.2337/db24-0756}
}
EUVIMED